Seminars

View More »

FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

  • Peggy Berry
  • San Francisco, CA | November 7-8, 2019

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada

  • Peggy Berry
  • San Francisco, CA | November 14-15, 2019

Quality Control Laboratory Compliance - cGMPs and GLPs

  • David L Chesney
  • San Jose, CA | November 18-19, 2019

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

  • David Nettleton
  • San Francisco, CA | November 20-21, 2019

Preparing for FDA's New Import/Export Trauma in 2020

  • Casper Uldriks
  • Chicago, IL | December 12-13, 2019

REACH and RoHS Compliance: Gain a Deeper Understanding

  • Kelly Eisenhardt
  • San Diego, CA | February 6-7, 2020

Designing and Sustaining New and Existing Product Stability Testing Program

  • Charity Ogunsanya
  • San Francisco, CA | February 13-14, 2020

FDA Recalls - Before You Start, and After You Finish

  • Casper Uldriks
  • San Francisco, CA | March 26-27, 2020
  • reduce-costs-for-compliance-with-data-integrity
  • quality-control-laboratory-compliance-cgmps-and-glps

You Recently Viewed